UW Radiology

Research Labs & Groups

CECORC brings together researchers conducting cost-effectiveness and outcomes studies that are interdisciplinary and emphasize cost as well as outcome for the comparative evaluation of approaches to existing and new technologies and procedures.

The Image-Guided Bio-Molecular Interventions Laboratory research team consists of physicians and medical-related professionals, with its primary goal of facilitating clinical translation of innovative imaging and interventional technologies.

The Imaging Research Laboratory is a multidisciplinary team committed to advancing tomographic medical imaging which uses ionizing radiation.

The Integrated Brain Imaging Center is an interdisciplinary home to faculty, support scientists, and trainees from a variety of medical, quantitative, and social scientific fields. 

At the Metabolic Spectroscopy Laboratory, the three broad areas covered by our research programs are: animal research, human research and spectroscopy and imaging.  

The Neuroimaging Research Laboratory’s primary focus is the development and application of novel imaging techniques to investigate neuropsychiatric disorders. 

The Northwest Screening and Cancer Outcomes Research Enterprise (NW-SCORE) is a unique partnership between UW Medicine and community radiology and pathology practices to aggregate de-identified breast imaging data to improve population-based screening outcomes. 

The Quantitative Breast Imaging Laboratory brings together a world class team of physicians and scientists to investigate new imaging techniques and to develop robust quantitative imaging biomarkers. 

The Vascular Imaging Laboratory is a multidisciplinary group of physicists, engineers, histologists and clinician-scientists with two key areas of focus: i) development of novel techniques for magnetic resonance image acquisition and analysis with histological validation; and ii) application of these techniques in multicenter studies examining mechanisms of vascular disease progression and associated ischemic complications, and in clinical trials to assess response to therapy.